Artificial pancreas implant shows promise for diabetes control

NCT ID NCT02064309

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tested a device called Beta-Air, which contains insulin-producing cells, in 4 adults with long-standing type 1 diabetes. The main goal was to see if the implant is safe. Researchers also checked if it could help control blood sugar and reduce dangerous low blood sugar episodes. The device is designed to work like a bioartificial pancreas.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LONG-STANDING TYPE 1 DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Uppsala University Hospital

    Uppsala, SE-75123, Sweden